Related references
Note: Only part of the references are listed.The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity
Daniel E. Foxler et al.
NATURE CELL BIOLOGY (2012)
Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
Nadine Rohwer et al.
DRUG RESISTANCE UPDATES (2011)
Targeted Therapies for Hepatocellular Carcinoma
Augusto Villanueva et al.
GASTROENTEROLOGY (2011)
Overexpression of von Hippel-Lindau protein synergizes with doxorubicin to suppress hepatocellular carcinoma in mice
Jizhou Wang et al.
JOURNAL OF HEPATOLOGY (2011)
Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells
Eunyoung Tak et al.
JOURNAL OF HEPATOLOGY (2011)
Double-Transduced MDCKII Cells To Study Human P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Interplay in Drug Transport across the Blood-Brain Barrier
Birk Poller et al.
MOLECULAR PHARMACEUTICS (2011)
Diphenyl Difluoroketone: A Potent Chemotherapy Candidate for Human Hepatocellular Carcinoma
Yingjian Liang et al.
PLOS ONE (2011)
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
John M. L. Ebos et al.
CANCER CELL (2009)
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes et al.
CANCER CELL (2009)
Sorafenib in Advanced Hepatocellular Carcinoma: A Further Step Toward Personalized Therapy of Liver Cancer
Massimo Colombo
GASTROENTEROLOGY (2009)
The evasive promise of antiangiogenic therapy
Jean-François Dufour
JOURNAL OF HEPATOLOGY (2009)
EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1
Shala L. Thomas et al.
CELL CYCLE (2008)
Diagnosis and treatment of hepatocellular carcinoma
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Drug resistance and the solid tumor microenvironment
Olivier Tredan et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models
Yong S. Chang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Mechanism of regulation of the hypoxia-inducible factor-lα by the von Hippel-Lindau tumor suppressor protein
K Tanimoto et al.
EMBO JOURNAL (2000)
Share Paper
